Impact of AT2 Receptor Deficiency on Postnatal Cardiovascular Development

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Biermann, Daniel ^a   Heilmann, Andreas ^b   Didié, Michael ^c   Schlossarek, Saskia ^b   Wahab, Azadeh ^b   Grimm, Michael ^b,d   Römer, Maria ^b   Reichenspurner, Hermann ^a   Sultan, Karim R ^b,e   Steenpass, Anna ^b   Ergün, Süleyman ^f   Donzelli, Sonia ^b   Carrier, Lucie ^b   Ehmke, Heimo ^b   Zimmermann, Wolfram H ^c   Hein, Lutz ^g   Böger, Rainer H ^b   Benndorf, Ralf A ^f,h  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LPT Laboratory of Pharmacology and Toxicology   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CALCIUM ION; ISOPRENALINE; MESSENGER RNA; PROTEIN BAX; S6 KINASE;

ADOLESCENT; ADULT ANIMAL; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE; BODY WEIGHT; CALCIUM CURRENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EX VIVO STUDY; GENE EXPRESSION; GENOTYPE; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART WEIGHT; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; RECEPTOR DENSITY; SARCOMERE; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; BCL-2-ASSOCIATED X PROTEIN; BLOOD PRESSURE; BODY WEIGHT; CALCIUM; CARDIOTONIC AGENTS; GENE EXPRESSION; HEART; IMMUNOBLOTTING; ISOPROTERENOL; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMERES; SIGNAL TRANSDUCTION; TIME FACTORS; VASOCONSTRICTOR AGENTS;

ANIMALIA; MUS;

EID: 84868152458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047916     Document Type: Article

References (42)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-52.
2. McMurray JJ, Pfeffer MA, (2005) Heart failure. Lancet 365: 1877-89.
3. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, et al. (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139: 244-52.
4. Galle J, (2008) Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med 5: 36-43.
5. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T, (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-72.
6. Beinlich CJ, White GJ, Baker KM, Morgan HE, (1991) Angiotensin II and left ventricular growth in newborn pig heart. J Mol Cell Cardiol 23: 1031-8.
7. Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y, (1994) Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction. J Hypertens Suppl 12: 153-7.
8. Sánchez SI, Seltzer AM, Fuentes LB, Forneris ML, Ciuffo GM, (2008) Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol 88: 114-23.
9. Madsen K, Marcussen N, Pedersen M, Kjaersgaard G, Facemire C, et al. (2010) Angiotensin II promotes development of the renal microcirculation through AT1 receptors. J Am Soc Nephrol 21: 448-59.
10. Velázquez-Armenta EY, Han JY, Choi JS, Yang KM, Nava-Ocampo AA, (2007) Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. Hypertens Pregnancy 26: 51-66.
11. Price RL, Carver W, Simpson DG, Fu L, Zhao J, et al. (1997) The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns. Dev Biol 192: 572-84.
12. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE, (2008) AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 120: 292-316.
13. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M, (1992) Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 71: 1482-9.
14. Hutchinson HG, Hein L, Fujinaga M, Pratt RE, (1999) Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 41: 689-700.
15. Shanmugam S, Corvol P, Gasc JM, (1996) Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 28: 91-7.
16. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK, (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377: 744-7.
17. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, et al. (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95: 187-95.
18. Benndorf RA, Krebs C, Hirsch-Hoffmann B, Schwedhelm E, Cieslar G, et al. (2009) Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int 75: 1039-49.
19. Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, et al. (2008) Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis. Circ Res 103: 1037-46.
20. Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, et al. (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes, Circ. Res 101: 928-938.
21. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-53.
22. Butz GM, Davisson RL, (2001) Long-term telemetric measurement of cardiovascular parameters in awake mice: aphysiological genomics tool. Physiol Genomics 5: 89-97.
23. Kuwahara K, Nakao K, (2010) Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones. Endocr J 57: 555-65.
24. Horiuchi M, Akishita M, Dzau VJ, (1998) Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 24: 307-14.
25. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E Jr, et al. (2003) A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO 2: 6471-82.
26. Munk VC, Sanchez de Miguel L, Petrimpol M, Butz N, Banfi A, et al. (2007) Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension 49: 1178-85.
27. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T, (2003) Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 93: 438-47.
28. Schütz S, Le Moullec JM, Corvol P, Gasc JM, (1996) Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 149: 2067-79.
29. van Esch JH, Gembardt F, Sterner-Kock A, Heringer-Walther S, Le TH, et al. (2010) Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. Cardiovasc Res 86: 401-9.
30. Gross V, Milia AF, Plehm R, Inagami T, Luft FC, (2000) Long-term blood pressure telemetry in AT2 receptor-disrupted mice. J Hypertens 18: 955-61.
31. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, et al. (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-90.
32. Gao L, Zucker IH, (2011) AT2 receptor signaling and sympathetic regulation. Curr Opin Pharmacol 11: 124-30.
33. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, et al. (1998) Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17: 6649-59.
34. Peterson RT, Schreiber SL, (1998) Translation control: connecting mitogens and the ribosome. Curr Biol 8: 248-50.
35. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, et al. (2002) Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 90: 1072-9.
36. Falcón BL, Veerasingham SJ, Sumners C, Raizada MK, (2005) Angiotensin II type 2 receptor-mediated gene expression profiling in human coronary artery endothelial cells. Hypertension 45: 692-7.
37. Kang KH, Park SY, Rho SB, Lee JH, (2008) Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Cardiovasc Res 79: 150-60.
38. Kou B, Vatish M, Singer DR, (2007) Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response. Vascul Pharmacol 47: 199-208.
39. Gomez Llambi H, Manni F, La Padula P, Carretero OA, Taquini CM, (1996) Myocardial contractility is modulated by angiotensin II via nitric oxide. Hypertension 27: 704-8.
40. Yang Z, Bove CM, French BA, Epstein FH, Berr SS, et al. (2002) Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 106: 106-11.
41. Avkiran M, Haworth RS, (2003) Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance. Cardiovasc Res 57: 942-52.
42. Lamparter S, Sun Y, Weber KT, (1999) Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart. Cardiovasc Res 43: 165-72.